urinary infection
Chrysopogon zizanioides(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys apical bud, decoction, orally2 |
Recommandations
Preparation and posology References |
According to published and other information: The uses of root decoction against insomnia, nervousness and cough are classified as REC, based on the significant traditional use documented in the TRAMIL surveys, toxicity studies, scientific validation and available published scientific information. The use of root decoction against abdominal pain, and the use of leaf and root decoction for headache are classified as REC, based on the significant traditional use documented in the TRAMIL surveys and toxicity studies. The use of apical bud decoction for stomach pain is classified as REC, based on the significant traditional use documented in the TRAMIL surveys, toxicity studies, scientific validation and available published scientific information. The use of apical bud decoction for urinary infection is classified as REC, based on the significant traditional use documented in the TRAMIL surveys and toxicity studies. The use of root and entire plant decoction by ingestion and in baths for high temperature (fever) is classified as REC, based on the significant traditional use documented in the TRAMIL surveys and toxicity studies. Should there be a notable worsening of the patient’s condition, or should symptoms persist for more than 2 days for high temperature (fever) and headache, for more than 3 days for stomach pain and urinary infection, or for more than 7 days for nervousness, seek medical attention. |
There is no available information establishing a means of preparation and dosage other than that referred to by traditional use. Any medicinal preparation must be preserved cold and used within the 24 hours. |
1 WENIGER B, ROUZIER M, 1986 2 GIRÓN L, 1988 3 LAGOS-WITTE S, 1988-89, 1996 4 SOLÍS PN, RODRÍGUEZ N, ESPINOSA A, GUPTA MP, 2004 5 SHIBAMOTO T, NISHIMURA O, 1982 6 WEYERSTAHL P, MARSCHALL H, SPLITTGERBER U, WOLF D, 1997 7 WEYERSTAHL P, MARSCHALL H, SPLITTGERBER U, WOLF D, 1996 8 LU Y, 1989 9 CÁCERES A, GONZÁLEZ S, GIRÓN L, 1998 10 SOLÍS PN, RODRÍGUEZ N, ESPINOSA A, GUPTA MP, 2004 11 GARCÍA GM, COTO MT, GONZÁLEZ CS, PAZOS L, 2000 12 GARCÍA GM, COTO MT, GONZÁLEZ CS, PAZOS L, 2000 13 PAZOS L, COTO MT, GONZÁLEZ CS, QUIROS S, 2003 14 CAMBAR P, COUSIN L, SANTOS A, ALGER J, 1989 15 PAZOS L, COTO T, GONZÁLEZ S, QUIROS S, 2004 16 CAMBAR P, 1996 17 AMDUR MD, MEAD J, 1958 18 JAIN SC, NOWICKI S, EISNER T, MEINWALD J, 1982 19 DIKSHIT A, HUSAIN A, 1984 20 SINGH B, AGRAWAL S, 1988 21 KINDRA K, SATYANARAYANA T, 1978 22 CHAUMONT J, BARDEY I, 1989 23 GANGRADE SK, SHRIVASTAVA RD, SHARMA OP, JAIN NK, TRIVEDI KC, 1991 24 PELLEGRINO J, 1967 25 PAZOS L, COTO T, GONZÁLEZ S, 2003 26 PAZOS L, COTO T, GONZÁLEZ S, 2003 27 PAZOS L, COTO T, GONZÁLEZ S, 2003 28 HIRUMA-LIMA CA, SOUZA BRITO AR, 2002 29 PAZOS L, COTO T, GONZÁLEZ S, 2003 30 PAZOS L, COTO T, GONZÁLEZ S, 2003 |
||
Cocos nucifera(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys fruit water, fresh, orally5 |
Recommandations
Preparation and posology References |
According to available information: Use for asthma, asthenia and weakness is classified as REC, based on the significant traditional use documented in the TRAMIL surveys, and on available published scientific information. Should there be a notable worsening of the patient’s condition, or should asthma last more than 2 days, seek medical attention. There is no information available on this resource for asthmatic crisis. Use for urinary infections is classified as REC, based on the significant traditional use documented in the TRAMIL surveys, and on available published scientific information. Due to the health risks involved with asthma, urinary infection or renal stones, an initial medical evaluation is recommended. The use of this resource can be considered complementary to medical treatment, unless it is contraindicated. Should there be a notable worsening of the patient’s condition, or should urinary infection symptoms last more than 3 days, seek medical attention. Not for use as an orally administered medicine during pregnancy, during lactation or by children under 5 years old. External use for arthritis, flu, burns and nacíos (boils) is classified as REC, based on the significant traditional use (OMS/WHO)6 documented in the TRAMIL surveys. Limit traditional use only to superficial burns (skin injury) that are not extensive (covering less than 10% of body surface) and are located away from high risk areas such as face, hands, feet and genitals. For topical application, strict hygiene measures should be observed in order to avoid contamination or additional infection. Should there be a notable worsening of the patient’s condition, or should boils persist for more than 5 days, seek medical attention. |
The fruit (seed, mesoderm) and the juice (water) of Cocos nucifera is widely used for human consumption. TRAMIL Research31 For asthma: Drink 15-30 mL (1-2 spoonfuls) of coconut oil 2-3 times a day. For urinary ailments: Drink 250 mL (1 cup) of coconut water 4-6 times a day31. For arthritis, nacíos (boils), flu and burns: There is no available information establishing a means of preparation and dosage other than that referred to by traditional use. |
1 BALLAND V, GLASGOW A, SPRINGER F, GAYMES G, 2004 TRAMIL survey. enda-caribbean, IICA, UAG & U.PARIS XI, Saint Vincent. 2 GERMOSEN-ROBINEAU L, GERONIMO M, AMPARO C, 1984 Encuesta TRAMIL. enda-caribe, Santo Domingo, Rep. Dominicana. 3 LAGOS-WITTE S, 1988-89, 1996 Encuesta TRAMIL. Laboratorio de Histología Vegetal y Etnobotánica, Departamento de Biología, Universidad Nacional Autónoma de Honduras UNAH, Tegucigalpa, Honduras. 4 CHARLES C, 1988 TRAMIL survey. Movement for Cultural Awareness MCA, Roseau, Dominica. 5 GIRON L, 1988 Encuesta TRAMIL (Costa atlántica). Centro Mesoamericano de Tecnología CEMAT, Guatemala, Guatemala. 6 WHO, 1991 Pautas para la evaluación de medicamentos herbarios WHO/TRM/91.4 (original inglés). Programa de Medicina Tradicional, OMS, Ginebra, Suiza. 7 MOURAFE J, BROWN WH, WHITING FM, STULL JW, 1975 Unsaponifiable matter of crude and processed coconut oil. J Sci Food Agr26:523. 8 PARIS R, MOYSE H, 1981 Précis de matière médicale.Paris, France: Ed. Maloine. 9 SAITTAGAROON S, KAWAKISHI S, NAMIKI M, 1985 Generation of mannitol from copra meal. J Food Sci50(3):757-760. 10 ATAKEUCHI K, 1961 Amino acids in the endosperm of some Amazonian Palmae. Chiba Daigaku Buurii Gakuba Kiyo Shizen Kagaku 3:321-325. 11 JANSZ ER, JEYA RAJ EE, PIERIS N, ABEYRATNE DJ, 1974 Cyanide liberation from linamarin. J Natl Sci Counc Sri Lanka 2:57-65. 12 KINDERLERER JL, KELLARD B, 1987 Alkylpyrazines produced by bacterial spoilage of heat-treated and gamma-irradiated coconut. Chem Ind (London) 16:567-568. 13 MANNAN A, AHMAD K, 1966 Studies on vitamin E in foods of East Pakistan. Pak J Biol Agr Sci9:13. 14 DUKE JA, ATCHLEY AA, 1986 Handbook of proximate analysis tables of higher plants.Boca Raton, USA: CRC Press. p47. 15 CAMBAR P, ALGER J, 1989 Efectos broncopulmonares del aceite de coco en conejos. Informe TRAMIL. Unidad de Farmacología, Facultad de Ciencias Medicas, Universidad Nacional Autónoma de Honduras UNAH, Tegucigalpa, Honduras. 16 CAMBAR P, 1987 Prevención de la producción de úlceras gástricas experimentales por algunos extractos de plantas.Informe TRAMIL. Unidad de Farmacología, Facultad de Ciencias Médicas, Universidad Nacional Autónoma de Honduras UNAH, Tegucigalpa, Honduras. 17 CACERES A, GIRON LM, ALVARADO SR, TORRES MF, 1987 Screening of antimicrobial activity of plants popularly used in Guatemala for the treatment of dermatomucosal diseases. J Ethnopharmacol 20(3):223-237. 18 VENKATARAMAN S, RAMANUJAN T, VENKATASUBBU V, 1980 Antifungal activity of the alcoholic extract of coconut shellCocos nucifera L. J Ethnopharmacol2(3):291-293. 19 JAIN SK, AGRAWAL SC, 1992 Sporostatic effect of some oils against fungi causing otomycosis. Indian J Med Sci 46(1):1-6. 20 CACERES A, MENENDEZ H, MENDEZ E, COHOBON E, SAMAYAO BE, JAUREGUI E, PERALTA E, CARRILLO G, 1992 Antigonorrhoeal activity of plants used in Guatemala for the treatment of sexually transmitted diseases. Facultad de Ciencias Químicas y Farmacia, Universidad de San Carlos, Guatemala, Guatemala. TRAMIL VI, Basse Terre, Guadeloupe, UAG/enda-caribe. 21 CACERES A, MENENDEZ H, MENDEZ E, COHOBON E, SAMAYAO BE, JAUREGUI E, PERALTA E, CARRILLO G, 1995 Antigonorrhoeal activity of plants used in Guatemala for the treatment of sexually transmitted diseases. J Ethnopharmacol48(2):85-88. 22 CACERES A, GIRON LM, MARTINEZ AM, 1987 Diuretic activity of plants used for the treatments of urinary ailments in Guatemala. J Ethnopharmacol19(3):233-245. 23 RODRÍGUEZ M, SÁNCHEZ C, 1982 Diuresis del agua de pipa (Cocos nucifera) en ratas. Rev Méd Panamá 7(3):186-19l. 24 KETUSINH O, 1954 Risks associate with intravenous infusion of coconut juice. J Med Ass Thailand 37(5):249-271. 25 MORTON J, 1981 Atlas of medicinal plants of Middle America.Springfield, USA: III: Charles C. Thomas Publisher. 26 BOOTH AN, BICKOFF EM, KOHLER GO, 1960 Estrogen-like activity in vegetable oils and mill by-products. Science 131:1807. 27 SALERNO JW, SMITH DE, 1991 The use of sesame oil and other vegetable oils in the inhibiting of human colon cancer growth in vitro. Anticancer Res 11(1):209-215. 28 LOCNISKAR M, BELURY MA, CUMBERLAND AG, PATRICK KE, FISCHER SM, 1991 The effect of dietary lipid on skin tumor promotion by benzoyl peroxide, comparison of fish, coconut and corn oil. Carcinogenesis 12(6):1023-1028. 29 BERTON TR, FISCHER SM, CONTI CJ, LOCNISKAR MF, 1996 Comparison of ultraviolet light-induced skin carcinogenesis and ornithine decarboxylase activity in sencar and hairless SKH-1 mice fed a constant level of dietary lipid varying in corn and coconut oil. Nutr Cancer 26(3):353-363. 30 CHINDAVANIG A, 1971 Effect of vegetable oils in plasma cholesterol in man and dog. Master Thesis, Dept. Biochemistry, Mahidol University, Bangkok, Thailand. 31 CARBALLO A, 1995 Cálculo de concentración y dosis de las drogas vegetales TRAMIL: Mensuraciones farmacognósticas y aproximaciones técnico-clínicas. Laboratorio Provincial de Producción de Medicamentos, Sancti Spiritus, Cuba. 32 Olmedo D, RODRIGUEZ N, ESPINOSA A, VASQUEZ Y, Gupta MP, 2005 Ensayo antimicrobiano de algunas especies con usos significativos TRAMIL-Centroamérica. Informe TRAMIL. Centro de Investigaciones Farmacognósticas de la Flora Panameña CIFLORPAN, Facultad de Farmacia, Universidad de Panamá, Panamá, Panamá. 33 GarcIa-GONZÁLEZ M, BARBOZA CJ, 2005 Velocidad del tránsito intestinal en ratones, del extracto acuoso del fruto fresco de Cocos nucifera. Informe TRAMIL. PRONAPLAMED. Depto de Fisiología, Escuela de Medicina, Universidad de Costa Rica, San Pedro, Costa Rica. 34 GarcIa-GONZÁLEZ M, BARBOZA CJ, 2005 Toxicidad aguda dosis repetida, en ratones, del extracto acuoso del aceite del fruto de Cocos nucifera. Informe TRAMIL.PRONAPLAMED. Depto de Fisiología, Escuela de Medicina, Universidad de Costa Rica, San Pedro, Costa Rica. 35 GarcIa-GONZÁLEZ M, BARBOZA CJ, 2005 Toxicidad aguda (5000 mg/kg) dosis repetida, en ratones, del extracto acuoso (decocción) del fruto fresco de Cocos nucifera. Informe TRAMIL.PRONAPLAMED. Depto de Fisiología, Escuela de Medicina, Universidad de Costa Rica, San Pedro, Costa Rica. 36 PAZOS L, COTO T, GONZALEZ S, 2006 Toxicidad oral subcrónica, dosis repetida, en ratón, de aceite del fruto fresco de Cocus nucifera. Informe TRAMIL. Laboratorio de Ensayos Biológicos, LEBi, Universidad de Costa Rica, San Pedro, Costa Rica. 37 PAZOS L, COTO T, GONZALEZ S, 2006 Irritabilidad dérmica, piel lesionada en conejos, del aceite del fruto puro de Cocus nucifera. Informe TRAMIL. Laboratorio de Ensayos Biológicos, LEBi, Universidad de Costa Rica, San Pedro, Costa Rica. 38 PAZOS L, COTO T, REYES L, 2007 Antiinflamatorio tópico, en ratones, del aceite del fruto de Cocus nucifera. Informe TRAMIL, Laboratorio de Ensayos Biológicos, LEBi, Universidad de Costa Rica, San Pedro, Costa Rica.
|
||
Persea americana(In territories with significant traditional TRAMIL use)
Significant uses found by the TRAMIL surveys leaf, decoction, orally2 |
Recommandations
Preparation and posology References |
According to published and other information: Use for amenorrhea is classified as REC, based on the significant traditional use documented in the TRAMIL surveys, toxicity studies, scientific validation and available published scientific information. Use for asthma, bronchitis, flatulence, urinary infection and cough is classified as REC, based on the significant traditional use documented in the TRAMIL surveys and toxicity studies. Should there be a notable worsening of the patient’s condition, or should asthma, bronchitis or cough last more than 5 days, or should urinary infection persist for more than 3 days, seek medical attention. Due to the risks of documented interactions with warfarin and monoamine-oxidase inhibitors (MAOI), ingestion of the fruit decoction should be avoided by persons taking these medicines5. Not for use during lactation or by children under 3 years old.
Not for use during pregnancy because it may have abortifacient effect. |
The fruit of Persea americana is widely used for human consumption. For amenorrhea, asthma, bronchitis, flatulence, urinary infection and cough: Prepare a decoction with 20 grams (3 spoonfuls) of ground leaf in 1 liter (4 cups) of water, boil for at least 10 minutes in a covered pot. Filter, allow to cool and drink 1/2-1 cup 3-4 times a day26. Any medicinal preparation must be preserved cold and used within the 24 hours. |
1 GERMOSEN-ROBINEAU L, GERONIMO M, AMPARO C, 1984 Encuesta TRAMIL. enda-caribe, Santo Domingo, Rep. Dominicana. 2 GIRON L, 1988 Encuesta TRAMIL (Costa atlántica). Centro Mesoamericano de Tecnología CEMAT, Guatemala, Guatemala. 3 LONGUEFOSSE JL, NOSSIN E, 1990-95 Enquête TRAMIL. Association pour la valorisation des plantes médicinales de la Caraïbe AVPMC, Fort de France, Martinique. 4 MENDEZ M, MEDINA ML, DURAN R, 1996 Encuesta TRAMIL. Unidad de recursos naturales, Centro de Investigación Científica de Yucatán CICY, Mérida, México. 5 CANIGUERAL S, VILA R, RISCO E, PEREZ F, PORTILLO A, FREIXA B, MILO B, VANACLOCHA B, RIOS JL, MORALES MA, ALONSO JR, BACHILLER LI, PERIS JB, STUBING G, 2002 Persea americana. Vademecum de Fitoterapia, Editorial Masson, Barcelona, España, Feb. 26, 2003. URL: http://www.masson.es/book/fitoterapia.html 6 BERGH BO, SCORA RW, STOREY WB, 1973 Comparison of leaf terpenes in Persea subgenus persea. Bot Gaz (Chicago) 134:130-134. 7 KING JR, KNIGHT RJ, 1992 Volatile components of the leaves of various avocado cultivars. J Agric Food Chem 40(7):1182-1185. 8 DE ALMEIDA AP, MIRANDA MMFS, SIMONI IC, WIGG MD, LAGROTA MHC, COSTA SS, 1998 Flavonol monoglycosides isolated from the antiviral fractions of Persea americana (Lauraceae) leaf infusion. Phytother Res 12(8):562-567. 9 MERIÇLI F, MERIÇLI AH, YILMAZ F, YÜNCÜLER G, YÜNCÜLER O, 1992 Flavonoids of avocado (Persea americana) leaves. Acta Pharm Turc 34(2):61-63. 10 BATE-SMITH EC, 1975 Phytochemistry of proanthocyanidins. Phytochemistry 14(4):1107-1113. 11 MURAKOSHI S, ISOGAI A, CHANG CF, KAMIKADO T, SAKURAI A, TAMURA S, 1976 The effects of two components from avocado leaves (Persea americana) and related compounds on the growth of silkworm larvae, Bombyx mori. Nippon Oyo Dobutsu Konchu Gakkaishi 20:87-91. 12 HIRAI N, KOSHIMIZU K, 1983 A new conjugate of dihydrophaseic acid from avocado fruit. Agr Biol Chem 47(2):365-371. 13 WILSON C, WILSON III CW, SAW PE, NAGY S, 1979 Analysis of monosaccharides in avocado by HPLC. Liq Chromat Anal Food Beverages 1:225-236. 14 SARDI JC, TORRES OA, 1978 Study on avocado (Persea americana) oil. Arch Bioquim Quim Farm 20:45-49. 15 DUKE JA, ATCHLEY AA, 1986 Handbook of proximate analysis tables of higher plants. Boca Raton, USA: CRC Press. p324. 16 CACERES A, GONZALEZ S, GIRON L, 1998 Demostración de la actividad antimicrobiana de plantas TRAMIL en base a los usos populares en la cuenca del Caribe. Informe TRAMIL. Laboratorio de productos fitofarmacéuticos Farmaya y Facultad de ciencias químicas y farmacia, Universidad de San Carlos, Guatemala, Guatemala. 17 HERRERA J, 1986 Determinación de actividades biológicas de vegetales utilizados en medicina tradicional. Informe TRAMIL. Dep. de Farmacología, Facultad de Salud, Universidad del Valle, Cali, Colombia. 18 GarcIa GM, Coto MT, GonzAlez CS, Pazos L, 1999 Actividad bronquial del extracto acuoso de hoja fresca de Persea americana. Informe TRAMIL. Laboratorio de Ensayos Biológicos LEBI, Escuela de Medicina, Universidad de Costa Rica, San Pedro, Costa Rica. 19 PAZOS L, COTO T, GONZALEZ S, QUIROS S, 2003 Tránsito intestinal, en ratones, del extracto acuoso de hojas frescas de Persea americana. Informe TRAMIL. Laboratorio de Ensayos Biológicos, Universidad de Costa Rica, San Pedro, Costa Rica. 20 ADEYEMI OO, OKPO SO, OGUNTI OO, 2002 Analgesic and anti-inflammatory effects of the aqueous extract of leaves of Persea americana Mill Lauraceae. Fitoterapia 73(5):375-380. 21 MIWA M, KONG ZL, SHINOHARA K, WATANABE M, 1990 Macrophage stimulating activity of foods. Agric Biol Chem 54(7):1863-1866. 22 HERRERA J, 1988 Determinación de actividades biológicas de vegetales utilizados en medicina tradicional. Informe TRAMIL. Laboratorio de fitofarmacología, Dep. de Farmacología, Facultad de Salud, Universidad del Valle, Cali, Colombia. 23 GarcIa GM, Coto MT, GonzAlez CS, Pazos L, 2000 Toxicidad aguda en ratones, del extracto acuoso de hojas frescas de Persea americana. Informe TRAMIL. Laboratorio de Ensayos Biológicos LEBI, Escuela de Medicina, Universidad de Costa Rica, San Pedro, Costa Rica. 24 CRAIGMILL AL, SEAWRIGHT AA, MATTILA T, FROST AJ, 1989 Pathological changes in the mammary gland and biochemical changes in milk of the goat following oral dosing with leaf of the avocado (Persea americana). Aust Vet J 66(7):206-211. 25 GRANT R, BASSON PA, BOOKER HH, HOFHERR JB, ANTHONISSEN M, 1991 Cardiomyopathy caused by avocado (Persea americana Mill.) leaves. J S Afr Vet Assoc 62(1):21-22. 26 ALONSO J, 1998 Tratado de fitomedicina. Bases clínicas y farmacológicas. Buenos Aires, Argentina: ISIS ediciones SRL. p185. 27 LOPEZ M, MARTINEZ MJ, MOREJON Z, BOUCOURT E, FUENTES V, MORON F. 2005 Irritabilidad dérmica primaria de hoja fresca machacada de Persea americana Mill. Informe TRAMIL. Laboratorio Central de Farmacología, Facultad de Medicina “Dr. Salvador Allende”, Cerro, C. Habana, Cuba. 28 MORON FJ, GARCIA AI, VICTORIA MC, MOREJON Z, LOPEZ M, BACALLAO Y, FUENTES V, 2008 Acción analgésica de la decocción de hojas frescas de Persea americana Mill. (aguacate) en ratones. Trabajo TRAMIL. Laboratorio Central de Farmacología. Universidad de Ciencias Médicas de La Habana. |